Apogenix to Present at Four Upcoming International Conferences
Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it will present updates on its three most advanced HERA-ligands as well as lead drug candidate asunercept at four upcoming international conferences.